Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yiyi Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2234-7588; OpenAlex author ID A5103078211. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 5 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 9

  1. Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects. Co-author DOI 10.1080/19490976.2025.2470372↗
  2. Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP. Co-author DOI 10.3389/fonc.2022.872017↗
  3. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. First author DOI 10.1038/s41421-021-00271-4↗
  4. A narrative review of Safety management of 1 L platinum-based chemotherapy and maintenance olaparib in BRCA mutated advanced pancreatic cancer. Co-author DOI 10.21037/tcr-20-3478↗
  5. Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.688953↗
  6. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.634167↗
  7. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Co-author DOI 10.3389/fonc.2021.693855↗
  8. Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer. Co-author DOI 10.1186/s12935-020-1135-0↗
  9. Oncogenic Activities Of UBE2S Mediated By VHL/HIF-1α/STAT3 Signal Via The Ubiquitin-Proteasome System In PDAC. First author DOI 10.2147/ott.s228522↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Gan · 5 shared papers, 2021–2025 · strength 0.77
  2. Hong Tu · 5 shared papers, 2021–2025 · strength 0.77
  3. Jin Li · 4 shared papers, 2021–2025 · strength 0.58
  4. Hui Cong · 4 shared papers, 2021–2025 · strength 0.58
  5. Jiujie Cui · 4 shared papers, 2020–2025 · strength 0.57
  6. Liwei Wang · 3 shared papers, 2021–2025 · strength 0.44
  7. Feng Jiao · 3 shared papers, 2020–2021 · strength 0.35
  8. Tiebo Mao · 2 shared papers, 2021 · strength 0.23
  9. Jiayu Yao · 2 shared papers, 2021 · strength 0.23
  10. Mengge Li · 2 shared papers, 2021 · strength 0.22
  11. Yuan Fang · 2 shared papers, 2021 · strength 0.22
  12. Haiyan Yang · 1 shared paper, 2021 · strength 0.13
  13. Meng Zhuo · 1 shared paper, 2020 · strength 0.13
  14. Ting Han · 1 shared paper, 2020 · strength 0.13
  15. Liwei Wang · 1 shared paper, 2020 · strength 0.13
  16. Wei Hu · 1 shared paper, 2019 · strength 0.11
  17. Lei Wang · 1 shared paper, 2019 · strength 0.11
  18. Pengping Li · 1 shared paper, 2019 · strength 0.11
  19. Xiaofei Zhang · 1 shared paper, 2021 · strength 0.10
  20. Qing Xia · 1 shared paper, 2021 · strength 0.10
  21. Jiong Hu · 1 shared paper, 2021 · strength 0.10
  22. Yongwei Sun · 1 shared paper, 2021 · strength 0.10
  23. Yu Wang · 1 shared paper, 2021 · strength 0.10
  24. Jing Xue · 1 shared paper, 2021 · strength 0.10
  25. Deliang Fu · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.